Index
NDX, S&P 500, RUI
Market Cap
37.98B
Enterprise Value
45.79B
Income
2.15B
Sales
21.64B
Book/sh
25.69
Cash/sh
6.31
Employees
54000
IPO
Dec 15, 2022
P/E
17.75
Forward P/E
15.22
PEG
1.51
P/S
1.76
P/B
3.27
P/C
13.31
P/FCF
20.11
EV/EBITDA
12.52
EV/Sales
2.12
Quick Ratio
0.95
Current Ratio
1.25
Debt/Eq
0.90
LT Debt/Eq
0.88
Option/Short
Yes / Yes
EPS (ttm)
4.73
EPS next Y
5.52
EPS next Q
1.56
EPS this Y
9.31%
EPS next Y
9.99%
EPS next 5Y
10.10%
EPS past 3/5Y
2.53% 0.61%
Sales past 3/5Y
3.99% 3.74%
EPS Y/Y TTM
-2.26%
Sales Y/Y TTM
6.87%
EPS Q/Q
39.11%
Sales Q/Q
7.19%
Insider Own
0.32%
Insider Trans
0.88%
Inst Own
93.04%
Inst Trans
-1.21%
ROA
5.78%
ROE
19.93%
ROIC
9.84%
Gross Margin
39.65%
Oper. Margin
14.03%
Profit Margin
9.96%
SMA20
11.10%
SMA50
20.32%
SMA200
20.20%
Trades
Shs Outstand
452.13M
Shs Float
450.69M
52W High
89.77 -6.42%
52W Low
58.75 43.00%
Volatility
3.84% 3.00%
ATR (14)
2.46
RSI (14)
73.94
Beta
0.73
Rel Volume
0.02
Avg Volume
3.61M
Volume
3,477
Perf Week
4.15%
Perf Month
24.02%
Perf Quarter
16.23%
Perf Half Y
34.87%
Perf YTD
2.43%
Perf Year
14.33%
Perf 3Y
20.84%
Perf 5Y
-
Perf 10Y
-
Prev Close
84.03
Price
84.01
Change %
-0.02%
Analysts 13 incl. previous ratings
Rating Distribution 7 Buy · 6 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 20, 2026 Initiated W Wolfe Research
Peer Perform Oct 07, 2026 Initiated B Barclays
Overweight $85 +1.2% Sep 22, 2026 Initiated N Needham
Buy $93 +10.7% Jul 09, 2026 Initiated B BMO Capital Markets
Market Perform $70 -16.7% Jun 23, 2026 Initiated R RBC Capital Mkts
Outperform $80 -4.8% May 21, 2026 Upgrade U UBS
Sell → Neutral $69 -17.9% Apr 30, 2026 Downgrade G Goldman
Buy → Neutral $65 -22.6% Jan 15, 2026 Downgrade U UBS
Neutral → Sell $77 -8.3% Oct 13, 2025 Initiated B Barclays
Equal Weight $86 +2.4% Oct 07, 2025 Downgrade C Citigroup
Buy → Neutral $83 -1.2% May 05, 2025 Upgrade U UBS
Sell → Neutral $73 -13.1% Mar 11, 2025 Upgrade G Goldman
Neutral → Buy $85 → $100 +19.0% Jan 08, 2025 Upgrade J Jefferies
Hold → Buy $95 → $103 +22.6% Sep 26, 2024 Downgrade U UBS
Neutral → Sell $84 → $74 -11.9% Sep 18, 2024 Upgrade B BTIG Research
Neutral → Buy $100 +19.0% Sep 09, 2024 Initiated J JP Morgan
Neutral $90 +7.1% Aug 06, 2024 Initiated S Stifel
Buy $100 +19.0% May 30, 2024 Initiated G Goldman
Neutral $87 +3.6% Feb 15, 2024 Initiated H HSBC Securities
Buy $100 +19.0% Feb 12, 2024 Upgrade U UBS
Sell → Neutral $66 → $88 +4.7%
Show Previous Ratings
Nov-06-26 10:36AM
Nov-05-26 05:29AM
Nov-03-26 08:00AM
Nov-01-26 12:35PM
Oct-29-26 08:53AM
12:01AM
Loading…
12:01AM
Oct-28-26 04:30PM
02:36PM
11:17AM
09:52AM
09:29AM
(Investor's Business Daily)
08:08AM
07:03AM
06:20AM
Oct-20-26 12:39PM
08:47AM
Loading…
Oct-16-26 08:47AM
05:14AM
Oct-15-26 08:00AM
Oct-12-26 10:15AM
Oct-07-26 10:00AM
08:00AM
Oct-05-26 12:15PM
11:22AM
10:52AM
09:23AM
08:38AM
08:00AM
07:30AM
(The Wall Street Journal)
Sep-22-26 05:25PM
04:05PM
02:20PM
Loading…
02:20PM
09:44AM
Sep-15-26 08:00AM
Sep-08-26 07:38AM
Sep-03-26 05:06PM
Sep-01-26 06:30AM
Aug-31-26 08:00AM
Aug-28-26 06:45AM
Aug-26-26 08:00AM
Aug-20-26 09:38AM
Aug-19-26 06:00AM
Aug-18-26 09:00AM
Jul-29-26 05:01PM
11:10AM
(Investor's Business Daily)
10:53AM
08:33AM
07:42AM
07:29AM
07:03AM
06:59AM
(The Wall Street Journal)
06:27AM
06:20AM
Jul-23-26 04:15PM
Jul-20-26 08:00AM
Jul-17-26 04:30PM
Jul-16-26 05:00AM
Jul-14-26 04:30PM
Jul-08-26 08:00AM
Jun-30-26 02:20PM
Jun-23-26 09:33AM
08:52AM
Jun-04-26 08:00AM
May-19-26 08:55AM
May-14-26 07:21AM
May-12-26 09:00AM
May-11-26 09:00AM
Apr-30-26 12:28PM
09:36AM
Apr-29-26 10:55AM
08:56AM
08:23AM
07:51AM
07:00AM
06:59AM
(The Wall Street Journal)
06:27AM
06:20AM
06:20AM
Apr-27-26 07:00AM
Apr-23-26 07:29AM
Apr-17-26 11:28AM
07:15AM
Apr-16-26 04:05PM
Apr-06-26 07:00AM
Mar-31-26 04:10PM
Mar-27-26 09:30AM
Mar-26-26 08:30AM
Mar-25-26 09:00AM
Mar-24-26 07:51AM
06:00AM
Mar-23-26 09:59AM
Mar-18-26 04:00PM
Mar-17-26 09:00AM
Mar-12-26 04:51PM
(The Wall Street Journal)
Mar-11-26 05:45AM
05:26AM
Mar-10-26 01:39PM
01:11PM
Mar-09-26 09:00AM
Mar-05-26 09:33AM
09:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
James Saccaro Former Officer Nov 04 '26 Proposed Sale 85.92 78,348 6,731,613 Nov 04 04:47 PM Lobo Kevin Director May 22 '26 Buy 64.18 10,000 641,800 14,363 May 26 06:44 PM Hochman Rodney F Director May 12 '26 Buy 62.03 1,618 100,365 1,618 May 13 04:19 PM Yang Watkin Phoebe L. Director May 08 '26 Buy 63.01 1,000 63,006 13,702 May 11 08:16 PM CULP H LAWRENCE JR Director May 06 '26 Buy 61.88 80,805 5,000,076 151,207 May 07 04:14 PM Stromberg William J Director May 06 '26 Buy 61.69 1,000 61,689 15,330 May 07 04:09 PM SACCARO JAMES Chief Financial Officer May 01 '26 Buy 60.60 3,310 200,585 87,471 May 01 11:38 AM Jimenez Frank R GC & Corporate Secretary Apr 30 '26 Buy 60.45 1,750 105,788 93,932 Apr 30 04:21 PM Arduini Peter J President and CEO Apr 30 '26 Buy 59.92 4,169 249,827 259,424 Apr 30 04:20 PM Kenneth Stacherski Former Officer Nov 24 '25 Proposed Sale 77.00 4,585 353,045 Nov 24 04:24 PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
President Mr. Peter J. Arduini
M.S. Dr. Taha Kass-Hout M.D.
General Counsel & Corporate Secretary Mr. Frank R. Jimenez Esq.
President & CEO of Patient Care Solutions Ms. Jeannette Bankes
Chief Financial Officer Mr. William K. Grogan